Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis

Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons

(2011) Andy I Choi et al.   AIDS

Abacavir use and cardiovascular disease events

(2011) Mario Cruciani et al.   AIDS

Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population

(2010) Sylvie Lang et al.   AIDS

Impact of Individual Antiretroviral Drugs on the Risk of Myocardial Infarction in Human Immunodeficiency Virus–Infected PatientsA Case-Control Study Nested Within the French Hospital Database on HIV ANRS Cohort CO4Antiretroviral Drugs, Risk of MI, and HIV

(2010) Sylvie Lang   ARCHIVES OF INTERNAL MEDICINE

Low CD4+T Cell Count Is a Risk Factor for Cardiovascular Disease Events in the HIV Outpatient Study

(2010) Kenneth A. Lichtenstein et al.   CLINICAL INFECTIOUS DISEASES

Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study

(2010) M. Aboud et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Simplification of Antiretroviral Therapy with Tenofovir‐Emtricitabine or Abacavir‐Lamivudine: A Randomized, 96‐Week Trial

(2009) Allison Martin et al.   CLINICAL INFECTIOUS DISEASES

Efficacy of Contact Lens Systems Against Recent Clinical and Tap Water Acanthamoeba Isolates

(2009) Megan E Shoff et al.   CORNEA

Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study

(2009) N Obel et al.   HIV MEDICINE

Physical Activity and All-cause Mortality: An Updated Meta-analysis with Different Intensity Categories

(2009) H. Löllgen et al.   INTERNATIONAL JOURNAL OF SPORTS MEDICINE

Association of HIV Infection, Demographic and Cardiovascular Risk Factors With All-Cause Mortality in the Recent HAART Era

(2009) Leslie Cockerham et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

(2009) Alessandro Liberati et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

(2009) Signe Westring Worm et al.   JOURNAL OF INFECTIOUS DISEASES

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE